athenahealth (NASDAQ:ATHN) released its quarterly earnings results on Friday. The health services provider reported $0.81 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.71 by $0.10, Morningstar.com reports. The firm had revenue of $331.40 million for the quarter, compared to analyst estimates of $336.98 million. athenahealth had a net margin of 8.71% and a return on equity of 14.71%. The business’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.56 EPS. athenahealth updated its FY 2018 guidance to EPS.
NASDAQ ATHN traded down $4.53 on Friday, reaching $120.35. The stock had a trading volume of 849,908 shares, compared to its average volume of 557,273. The firm has a market cap of $5.12 billion, a price-to-earnings ratio of 76.66, a PEG ratio of 2.23 and a beta of 0.80. The company has a quick ratio of 2.62, a current ratio of 2.62 and a debt-to-equity ratio of 0.23. athenahealth has a 12-month low of $116.77 and a 12-month high of $163.94.
Several analysts have recently commented on ATHN shares. Leerink Swann set a $138.00 price target on shares of athenahealth and gave the company a “hold” rating in a research report on Thursday, November 1st. BidaskClub raised shares of athenahealth from a “strong sell” rating to a “sell” rating in a research report on Saturday, October 13th. Cowen reaffirmed a “hold” rating and set a $150.00 price target on shares of athenahealth in a research report on Wednesday, August 1st. Royal Bank of Canada reaffirmed a “hold” rating and set a $140.00 price target on shares of athenahealth in a research report on Friday, September 28th. Finally, SunTrust Banks reduced their price target on shares of athenahealth to $150.00 in a research report on Wednesday, September 19th. One equities research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and six have given a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $153.79.
In other athenahealth news, insider Daniel P. Haley sold 2,204 shares of the business’s stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $127.23, for a total value of $280,414.92. Following the sale, the insider now owns 10,555 shares of the company’s stock, valued at $1,342,912.65. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In the last three months, insiders sold 2,654 shares of company stock worth $340,770. 2.90% of the stock is owned by corporate insiders.
Hedge funds and other institutional investors have recently made changes to their positions in the business. Integrated Investment Consultants LLC purchased a new stake in athenahealth in the second quarter valued at approximately $150,000. Ropes Wealth Advisors LLC purchased a new stake in shares of athenahealth during the second quarter worth $194,000. Campbell & CO Investment Adviser LLC purchased a new stake in shares of athenahealth during the second quarter worth $206,000. Strs Ohio purchased a new stake in shares of athenahealth during the second quarter worth $208,000. Finally, Hengehold Capital Management LLC purchased a new stake in shares of athenahealth during the second quarter worth $214,000.
athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.
Featured Story: Risk Tolerance
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.